 | • レポートコード：QFJ1-3955 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、がんホルモン療法剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（タモキシフェン、アロマターゼ阻害剤、抗アンドロゲン剤、アンドロゲン合成阻害剤、その他）、用途別市場規模（乳がん、前立腺がん）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・がんホルモン療法剤の市場動向 ・企業の競争状況、市場シェア ・がんホルモン療法剤の種類別市場規模と予測2016-2027（タモキシフェン、アロマターゼ阻害剤、抗アンドロゲン剤、アンドロゲン合成阻害剤、その他） ・がんホルモン療法剤の用途別市場規模と予測2016-2027（乳がん、前立腺がん） ・がんホルモン療法剤の北米市場規模2016-2027（アメリカ、カナダ） ・がんホルモン療法剤の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・がんホルモン療法剤のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・がんホルモン療法剤の中南米市場規模2016-2027（メキシコ、ブラジル） ・がんホルモン療法剤の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Roche、Amgen、Pfizer、Teva、Takeda、Samyang Biopharmaceuticals、Tolmar、AstraZeneca、Novartis、Aspen） ・結論 |
Hormone Therapy, (also called hormonal therapy, hormone treatment, or endocrine therapy) is a cancer treatment that blocks or lowers the growth of cancer that uses hormones to grow. Doctors use it to treat some cancers such as breast and prostate cancer.
Market Analysis and Insights: Global Cancer Hormone Therapy Drugs Market
The global Cancer Hormone Therapy Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cancer Hormone Therapy Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cancer Hormone Therapy Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cancer Hormone Therapy Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cancer Hormone Therapy Drugs market.
Global Cancer Hormone Therapy Drugs Scope and Market Size
Cancer Hormone Therapy Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Hormone Therapy Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Tamoxifen
Aromatase Inhibitors
Antiandrogens
Androgen Synthesis Inhibitors
Other
Segment by Application
Breast Cancer
Prostate Cancer
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Roche
Amgen
Pfizer
Teva
Takeda
Samyang Biopharmaceuticals
Tolmar
AstraZeneca
Novartis
Aspen
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Hormone Therapy Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Tamoxifen
1.2.3 Aromatase Inhibitors
1.2.4 Antiandrogens
1.2.5 Androgen Synthesis Inhibitors
1.2.6 Other
1.3 Market by Application
1.3.1 Global Cancer Hormone Therapy Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Breast Cancer
1.3.3 Prostate Cancer
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cancer Hormone Therapy Drugs Market Perspective (2016-2027)
2.2 Cancer Hormone Therapy Drugs Growth Trends by Regions
2.2.1 Cancer Hormone Therapy Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cancer Hormone Therapy Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Cancer Hormone Therapy Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Cancer Hormone Therapy Drugs Industry Dynamic
2.3.1 Cancer Hormone Therapy Drugs Market Trends
2.3.2 Cancer Hormone Therapy Drugs Market Drivers
2.3.3 Cancer Hormone Therapy Drugs Market Challenges
2.3.4 Cancer Hormone Therapy Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Hormone Therapy Drugs Players by Revenue
3.1.1 Global Top Cancer Hormone Therapy Drugs Players by Revenue (2016-2021)
3.1.2 Global Cancer Hormone Therapy Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Cancer Hormone Therapy Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cancer Hormone Therapy Drugs Revenue
3.4 Global Cancer Hormone Therapy Drugs Market Concentration Ratio
3.4.1 Global Cancer Hormone Therapy Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Hormone Therapy Drugs Revenue in 2020
3.5 Cancer Hormone Therapy Drugs Key Players Head office and Area Served
3.6 Key Players Cancer Hormone Therapy Drugs Product Solution and Service
3.7 Date of Enter into Cancer Hormone Therapy Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Hormone Therapy Drugs Breakdown Data by Type
4.1 Global Cancer Hormone Therapy Drugs Historic Market Size by Type (2016-2021)
4.2 Global Cancer Hormone Therapy Drugs Forecasted Market Size by Type (2022-2027)
5 Cancer Hormone Therapy Drugs Breakdown Data by Application
5.1 Global Cancer Hormone Therapy Drugs Historic Market Size by Application (2016-2021)
5.2 Global Cancer Hormone Therapy Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Cancer Hormone Therapy Drugs Market Size (2016-2027)
6.2 North America Cancer Hormone Therapy Drugs Market Size by Type
6.2.1 North America Cancer Hormone Therapy Drugs Market Size by Type (2016-2021)
6.2.2 North America Cancer Hormone Therapy Drugs Market Size by Type (2022-2027)
6.2.3 North America Cancer Hormone Therapy Drugs Market Size by Type (2016-2027)
6.3 North America Cancer Hormone Therapy Drugs Market Size by Application
6.3.1 North America Cancer Hormone Therapy Drugs Market Size by Application (2016-2021)
6.3.2 North America Cancer Hormone Therapy Drugs Market Size by Application (2022-2027)
6.3.3 North America Cancer Hormone Therapy Drugs Market Size by Application (2016-2027)
6.4 North America Cancer Hormone Therapy Drugs Market Size by Country
6.4.1 North America Cancer Hormone Therapy Drugs Market Size by Country (2016-2021)
6.4.2 North America Cancer Hormone Therapy Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Cancer Hormone Therapy Drugs Market Size (2016-2027)
7.2 Europe Cancer Hormone Therapy Drugs Market Size by Type
7.2.1 Europe Cancer Hormone Therapy Drugs Market Size by Type (2016-2021)
7.2.2 Europe Cancer Hormone Therapy Drugs Market Size by Type (2022-2027)
7.2.3 Europe Cancer Hormone Therapy Drugs Market Size by Type (2016-2027)
7.3 Europe Cancer Hormone Therapy Drugs Market Size by Application
7.3.1 Europe Cancer Hormone Therapy Drugs Market Size by Application (2016-2021)
7.3.2 Europe Cancer Hormone Therapy Drugs Market Size by Application (2022-2027)
7.3.3 Europe Cancer Hormone Therapy Drugs Market Size by Application (2016-2027)
7.4 Europe Cancer Hormone Therapy Drugs Market Size by Country
7.4.1 Europe Cancer Hormone Therapy Drugs Market Size by Country (2016-2021)
7.4.2 Europe Cancer Hormone Therapy Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Cancer Hormone Therapy Drugs Market Size (2016-2027)
8.2 Asia-Pacific Cancer Hormone Therapy Drugs Market Size by Type
8.2.1 Asia-Pacific Cancer Hormone Therapy Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cancer Hormone Therapy Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cancer Hormone Therapy Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Cancer Hormone Therapy Drugs Market Size by Application
8.3.1 Asia-Pacific Cancer Hormone Therapy Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cancer Hormone Therapy Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cancer Hormone Therapy Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Cancer Hormone Therapy Drugs Market Size by Region
8.4.1 Asia-Pacific Cancer Hormone Therapy Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cancer Hormone Therapy Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cancer Hormone Therapy Drugs Market Size (2016-2027)
9.2 Latin America Cancer Hormone Therapy Drugs Market Size by Type
9.2.1 Latin America Cancer Hormone Therapy Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Cancer Hormone Therapy Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Cancer Hormone Therapy Drugs Market Size by Type (2016-2027)
9.3 Latin America Cancer Hormone Therapy Drugs Market Size by Application
9.3.1 Latin America Cancer Hormone Therapy Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Cancer Hormone Therapy Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Cancer Hormone Therapy Drugs Market Size by Application (2016-2027)
9.4 Latin America Cancer Hormone Therapy Drugs Market Size by Country
9.4.1 Latin America Cancer Hormone Therapy Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Cancer Hormone Therapy Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Hormone Therapy Drugs Market Size (2016-2027)
10.2 Middle East & Africa Cancer Hormone Therapy Drugs Market Size by Type
10.2.1 Middle East & Africa Cancer Hormone Therapy Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cancer Hormone Therapy Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cancer Hormone Therapy Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Cancer Hormone Therapy Drugs Market Size by Application
10.3.1 Middle East & Africa Cancer Hormone Therapy Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cancer Hormone Therapy Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cancer Hormone Therapy Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Cancer Hormone Therapy Drugs Market Size by Country
10.4.1 Middle East & Africa Cancer Hormone Therapy Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cancer Hormone Therapy Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Cancer Hormone Therapy Drugs Introduction
11.1.4 Roche Revenue in Cancer Hormone Therapy Drugs Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Cancer Hormone Therapy Drugs Introduction
11.2.4 Amgen Revenue in Cancer Hormone Therapy Drugs Business (2016-2021)
11.2.5 Amgen Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Cancer Hormone Therapy Drugs Introduction
11.3.4 Pfizer Revenue in Cancer Hormone Therapy Drugs Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Teva
11.4.1 Teva Company Details
11.4.2 Teva Business Overview
11.4.3 Teva Cancer Hormone Therapy Drugs Introduction
11.4.4 Teva Revenue in Cancer Hormone Therapy Drugs Business (2016-2021)
11.4.5 Teva Recent Development
11.5 Takeda
11.5.1 Takeda Company Details
11.5.2 Takeda Business Overview
11.5.3 Takeda Cancer Hormone Therapy Drugs Introduction
11.5.4 Takeda Revenue in Cancer Hormone Therapy Drugs Business (2016-2021)
11.5.5 Takeda Recent Development
11.6 Samyang Biopharmaceuticals
11.6.1 Samyang Biopharmaceuticals Company Details
11.6.2 Samyang Biopharmaceuticals Business Overview
11.6.3 Samyang Biopharmaceuticals Cancer Hormone Therapy Drugs Introduction
11.6.4 Samyang Biopharmaceuticals Revenue in Cancer Hormone Therapy Drugs Business (2016-2021)
11.6.5 Samyang Biopharmaceuticals Recent Development
11.7 Tolmar
11.7.1 Tolmar Company Details
11.7.2 Tolmar Business Overview
11.7.3 Tolmar Cancer Hormone Therapy Drugs Introduction
11.7.4 Tolmar Revenue in Cancer Hormone Therapy Drugs Business (2016-2021)
11.7.5 Tolmar Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Cancer Hormone Therapy Drugs Introduction
11.8.4 AstraZeneca Revenue in Cancer Hormone Therapy Drugs Business (2016-2021)
11.8.5 AstraZeneca Recent Development
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis Cancer Hormone Therapy Drugs Introduction
11.9.4 Novartis Revenue in Cancer Hormone Therapy Drugs Business (2016-2021)
11.9.5 Novartis Recent Development
11.10 Aspen
11.10.1 Aspen Company Details
11.10.2 Aspen Business Overview
11.10.3 Aspen Cancer Hormone Therapy Drugs Introduction
11.10.4 Aspen Revenue in Cancer Hormone Therapy Drugs Business (2016-2021)
11.10.5 Aspen Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Cancer Hormone Therapy Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Tamoxifen
Table 3. Key Players of Aromatase Inhibitors
Table 4. Key Players of Antiandrogens
Table 5. Key Players of Androgen Synthesis Inhibitors
Table 6. Key Players of Other
Table 7. Global Cancer Hormone Therapy Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Cancer Hormone Therapy Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Cancer Hormone Therapy Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Cancer Hormone Therapy Drugs Market Share by Regions (2016-2021)
Table 11. Global Cancer Hormone Therapy Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Cancer Hormone Therapy Drugs Market Share by Regions (2022-2027)
Table 13. Cancer Hormone Therapy Drugs Market Trends
Table 14. Cancer Hormone Therapy Drugs Market Drivers
Table 15. Cancer Hormone Therapy Drugs Market Challenges
Table 16. Cancer Hormone Therapy Drugs Market Restraints
Table 17. Global Cancer Hormone Therapy Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Cancer Hormone Therapy Drugs Market Share by Players (2016-2021)
Table 19. Global Top Cancer Hormone Therapy Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Hormone Therapy Drugs as of 2020)
Table 20. Ranking of Global Top Cancer Hormone Therapy Drugs Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Cancer Hormone Therapy Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Cancer Hormone Therapy Drugs Product Solution and Service
Table 24. Date of Enter into Cancer Hormone Therapy Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cancer Hormone Therapy Drugs Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Cancer Hormone Therapy Drugs Revenue Market Share by Type (2016-2021)
Table 28. Global Cancer Hormone Therapy Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Cancer Hormone Therapy Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Cancer Hormone Therapy Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Cancer Hormone Therapy Drugs Revenue Market Share by Application (2016-2021)
Table 32. Global Cancer Hormone Therapy Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Cancer Hormone Therapy Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Cancer Hormone Therapy Drugs Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Cancer Hormone Therapy Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Cancer Hormone Therapy Drugs Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Cancer Hormone Therapy Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Cancer Hormone Therapy Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Cancer Hormone Therapy Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Cancer Hormone Therapy Drugs Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Cancer Hormone Therapy Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Cancer Hormone Therapy Drugs Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Cancer Hormone Therapy Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Cancer Hormone Therapy Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Cancer Hormone Therapy Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Cancer Hormone Therapy Drugs Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Cancer Hormone Therapy Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Cancer Hormone Therapy Drugs Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Cancer Hormone Therapy Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Cancer Hormone Therapy Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Cancer Hormone Therapy Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Cancer Hormone Therapy Drugs Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Cancer Hormone Therapy Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Cancer Hormone Therapy Drugs Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Cancer Hormone Therapy Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Cancer Hormone Therapy Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Cancer Hormone Therapy Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Cancer Hormone Therapy Drugs Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Cancer Hormone Therapy Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Cancer Hormone Therapy Drugs Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Cancer Hormone Therapy Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Cancer Hormone Therapy Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Cancer Hormone Therapy Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 64. Roche Company Details
Table 65. Roche Business Overview
Table 66. Roche Cancer Hormone Therapy Drugs Product
Table 67. Roche Revenue in Cancer Hormone Therapy Drugs Business (2016-2021) & (US$ Million)
Table 68. Roche Recent Development
Table 69. Amgen Company Details
Table 70. Amgen Business Overview
Table 71. Amgen Cancer Hormone Therapy Drugs Product
Table 72. Amgen Revenue in Cancer Hormone Therapy Drugs Business (2016-2021) & (US$ Million)
Table 73. Amgen Recent Development
Table 74. Pfizer Company Details
Table 75. Pfizer Business Overview
Table 76. Pfizer Cancer Hormone Therapy Drugs Product
Table 77. Pfizer Revenue in Cancer Hormone Therapy Drugs Business (2016-2021) & (US$ Million)
Table 78. Pfizer Recent Development
Table 79. Teva Company Details
Table 80. Teva Business Overview
Table 81. Teva Cancer Hormone Therapy Drugs Product
Table 82. Teva Revenue in Cancer Hormone Therapy Drugs Business (2016-2021) & (US$ Million)
Table 83. Teva Recent Development
Table 84. Takeda Company Details
Table 85. Takeda Business Overview
Table 86. Takeda Cancer Hormone Therapy Drugs Product
Table 87. Takeda Revenue in Cancer Hormone Therapy Drugs Business (2016-2021) & (US$ Million)
Table 88. Takeda Recent Development
Table 89. Samyang Biopharmaceuticals Company Details
Table 90. Samyang Biopharmaceuticals Business Overview
Table 91. Samyang Biopharmaceuticals Cancer Hormone Therapy Drugs Product
Table 92. Samyang Biopharmaceuticals Revenue in Cancer Hormone Therapy Drugs Business (2016-2021) & (US$ Million)
Table 93. Samyang Biopharmaceuticals Recent Development
Table 94. Tolmar Company Details
Table 95. Tolmar Business Overview
Table 96. Tolmar Cancer Hormone Therapy Drugs Product
Table 97. Tolmar Revenue in Cancer Hormone Therapy Drugs Business (2016-2021) & (US$ Million)
Table 98. Tolmar Recent Development
Table 99. AstraZeneca Company Details
Table 100. AstraZeneca Business Overview
Table 101. AstraZeneca Revenue in Cancer Hormone Therapy Drugs Business (2016-2021) & (US$ Million)
Table 102. AstraZeneca Recent Development
Table 103. Novartis Company Details
Table 104. Novartis Business Overview
Table 105. Novartis Cancer Hormone Therapy Drugs Product
Table 106. Novartis Revenue in Cancer Hormone Therapy Drugs Business (2016-2021) & (US$ Million)
Table 107. Novartis Recent Development
Table 108. Aspen Company Details
Table 109. Aspen Business Overview
Table 110. Aspen Cancer Hormone Therapy Drugs Product
Table 111. Aspen Revenue in Cancer Hormone Therapy Drugs Business (2016-2021) & (US$ Million)
Table 112. Aspen Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Hormone Therapy Drugs Market Share by Type: 2020 VS 2027
Figure 2. Tamoxifen Features
Figure 3. Aromatase Inhibitors Features
Figure 4. Antiandrogens Features
Figure 5. Androgen Synthesis Inhibitors Features
Figure 6. Other Features
Figure 7. Global Cancer Hormone Therapy Drugs Market Share by Application: 2020 VS 2027
Figure 8. Breast Cancer Case Studies
Figure 9. Prostate Cancer Case Studies
Figure 10. Cancer Hormone Therapy Drugs Report Years Considered
Figure 11. Global Cancer Hormone Therapy Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Cancer Hormone Therapy Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Cancer Hormone Therapy Drugs Market Share by Regions: 2020 VS 2027
Figure 14. Global Cancer Hormone Therapy Drugs Market Share by Regions (2022-2027)
Figure 15. Global Cancer Hormone Therapy Drugs Market Share by Players in 2020
Figure 16. Global Top Cancer Hormone Therapy Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Hormone Therapy Drugs as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Cancer Hormone Therapy Drugs Revenue in 2020
Figure 18. Global Cancer Hormone Therapy Drugs Revenue Market Share by Type (2016-2021)
Figure 19. Global Cancer Hormone Therapy Drugs Revenue Market Share by Type (2022-2027)
Figure 20. North America Cancer Hormone Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Cancer Hormone Therapy Drugs Market Share by Type (2016-2027)
Figure 22. North America Cancer Hormone Therapy Drugs Market Share by Application (2016-2027)
Figure 23. North America Cancer Hormone Therapy Drugs Market Share by Country (2016-2027)
Figure 24. United States Cancer Hormone Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Cancer Hormone Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Cancer Hormone Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Cancer Hormone Therapy Drugs Market Share by Type (2016-2027)
Figure 28. Europe Cancer Hormone Therapy Drugs Market Share by Application (2016-2027)
Figure 29. Europe Cancer Hormone Therapy Drugs Market Share by Country (2016-2027)
Figure 30. Germany Cancer Hormone Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Cancer Hormone Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Cancer Hormone Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Cancer Hormone Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Cancer Hormone Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Cancer Hormone Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Cancer Hormone Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Cancer Hormone Therapy Drugs Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Cancer Hormone Therapy Drugs Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Cancer Hormone Therapy Drugs Market Share by Region (2016-2027)
Figure 40. China Cancer Hormone Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Cancer Hormone Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Cancer Hormone Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Cancer Hormone Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Cancer Hormone Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Cancer Hormone Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Cancer Hormone Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Cancer Hormone Therapy Drugs Market Share by Type (2016-2027)
Figure 48. Latin America Cancer Hormone Therapy Drugs Market Share by Application (2016-2027)
Figure 49. Latin America Cancer Hormone Therapy Drugs Market Share by Country (2016-2027)
Figure 50. Mexico Cancer Hormone Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Cancer Hormone Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Cancer Hormone Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Cancer Hormone Therapy Drugs Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Cancer Hormone Therapy Drugs Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Cancer Hormone Therapy Drugs Market Share by Country (2016-2027)
Figure 56. Turkey Cancer Hormone Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Cancer Hormone Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Cancer Hormone Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Roche Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2016-2021)
Figure 60. Amgen Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2016-2021)
Figure 61. Pfizer Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2016-2021)
Figure 62. Teva Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2016-2021)
Figure 63. Takeda Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2016-2021)
Figure 64. Samyang Biopharmaceuticals Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2016-2021)
Figure 65. Tolmar Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2016-2021)
Figure 66. AstraZeneca Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2016-2021)
Figure 67. Novartis Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2016-2021)
Figure 68. Aspen Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
世界のホルモン不応性乳がん市場規模・現状・予測（2021年-2027年） An increasing number of hormone therapies have made refractory breast cancer resistant to treatment, increased incidence of breast cancer, aging population, increased demand for advanced therapies, increased incidence of hormone-refractory breast cancer and the existence of a large number of anti-ca…- ホルモン抵抗性乳癌のグローバル市場：規模・現状・予測2019-2025 An increasing number of hormone therapies have made refractory breast cancer resistant to treatment, increased incidence of breast cancer, aging population, increased demand for advanced therapies, increased incidence of hormone-refractory breast cancer and the existence of a large number of anti-ca…
- ホルモン抵抗性乳癌のグローバル市場：規模・現状・予測2019-2025 An increasing number of hormone therapies have made refractory breast cancer resistant to treatment, increased incidence of breast cancer, aging population, increased demand for advanced therapies, increased incidence of hormone-refractory breast cancer and the existence of a large number of anti-ca…
- ホルモン抵抗性乳癌のグローバル市場：規模・現状・予測2019-2025 An increasing number of hormone therapies have made refractory breast cancer resistant to treatment, increased incidence of breast cancer, aging population, increased demand for advanced therapies, increased incidence of hormone-refractory breast cancer and the existence of a large number of anti-ca…
- 世界の前立腺がん市場規模・現状・予測（2021年-2027年） Prostate cancer is cancer that occurs in the prostate. Market Analysis and Insights: Global Prostate Cancer Market The global Prostate Cancer market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in a…